Clinical trial

Open-Label of SPN-820 in Adults With Major Depressive Disorder

NCT06235905

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention NV-5138 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Open-Label of SPN-820 in Adults With Major Depressive Disorder

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-02-15

PhasePHASE2

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

NV-5138DRUG

Sponsors & collaborators

Navitor Pharmaceuticals, Inc.lead sponsor

Supernus Pharmaceuticals, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06235905 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.